The rising prices of pharmaceuticals have generated considerable, and often acrimonious, debate. Yet, there is little theoretical work or empirical evidence on pharmaceutical entry-pricing strategies or on the time paths of the prices of new entrants versus incumbents. This study explores the entry pricing strategies of pharmaceutical manufacturers. Previous theoretical models have considered a...

Background A number of factors play a role in market access of orphan drugs, such as the extent to which an orphan drug meets a medical need; existence of alternative health technologies; disease prevalence; number of orphan drug indications; and added clinical benefit of the orphan drug. How can these factors be taken into account in market access decisions given that there is uncertainty over...

for prolonging the time that drug remains in stomach, new methods used as floating drug delivery systems, that available in various forms such as floating tablets. these systems enhance drug absorption and decrease plasma concentration fluctuations. iron deficiency and its inadequate absorption in diet are of community health problems. for prolonging the time that drug remains in stomach, new m...

In order for organizations to survive on increasingly competitive and global markets, adequate management of intellectual capital is essential. Although increasingly more information is found in electronic formats, turning this information into valuable knowledge is still the responsibility of people by applying it in professional situations to generate value. In this paper, we describe an appr...

The development of the novel therapeutic agents or drugs will be widely affected by Parameters related to the chemistry (structure activity relationship), Pharmacology (mechanism of action of the drug) and the Pharmacokinetic profile of the drug (metabolism characteristics) will play an important role. Before a drug is newly launched in the market various pre clinical studies has to be undertak...

In 2003, Congress introduced new legislation to subsidize prescription drug insurance for Medicare recipients; Medicare “Part D” will cost nearly $1 trillion over the next ten years. In this paper, I analyze the incidence of this subsidy by inferring producer surplus from the stock market returns to pharmaceutical firms. I first obtain a measure of the profitability of each brand-name drug from...

Notwithstanding a century of prohibition, marijuana is the most widely used illicit substance in Canada. Due to the growing public acceptance of recreational marijuana use and ineffectiveness of the existing control system in Canada, the issue surrounding legalizing this illicit drug has received considerable public and political attentions in recent years. Consequently, the newly elected Liber...